Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

360
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
360
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

335
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
335
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

805
Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
805
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

734
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
734
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

1.0K
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning approaches for predicting Ki-67 index in breast cancer histopathology images: A systematic review.

Computers in biology and medicine·2026
Same author

Association of apolipoprotein E variants on Alzheimer's disease in Latin America: A systematic review and meta-analysis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Plasma ATN biomarkers across the alzheimer's disease continuum in a Chilean community- and clinic-based cohort.

Alzheimer's research & therapy·2026
Same author

Blood-based AT(N) biomarkers for Alzheimer's disease and frontotemporal lobar degeneration in Latin America.

Nature aging·2026
Same author

Chronic pain in the Chilean population: risk factors prevalence and cognitive associations.

Frontiers in aging·2025
Same author

Bayesian inference for nonlinear mixed-effects location scale and interval-censoring cure-survival models: An application to pregnancy miscarriage.

Statistical methods in medical research·2025

Related Experiment Video

Updated: May 7, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

2.9K

Bayesian analysis for nonlinear mixed-effects models under heavy-tailed distributions.

Rolando De la Cruz1

  • 1Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Statistics, Faculty of Mathematics, Pontificia Universidad Católica de Chile, Santiago, Chile.

Pharmaceutical Statistics
|October 10, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces robust nonlinear mixed-effects models using flexible distributions to handle outliers. The approach enhances statistical inference in pharmacokinetic studies by identifying unusual data points.

Keywords:
Gibbs samplerMCMC methodsmixed-effects modeloutliersrandom effectsscale mixture of normal distributions

More Related Videos

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

10.6K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.3K

Related Experiment Videos

Last Updated: May 7, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

2.9K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

10.6K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.3K

Area of Science:

  • Statistics
  • Pharmacokinetics
  • Biostatistics

Background:

  • Nonlinear mixed-effects models (NLME) commonly assume normal distributions for random effects and errors.
  • Normality assumptions in NLME models can lead to unreliable inferences when outliers are present.
  • Robust statistical methods are needed to address variability and outliers in NLME models.

Purpose of the Study:

  • To extend nonlinear mixed-effects models by incorporating a flexible class of distributions for random effects and within-subject errors.
  • To develop a robust statistical framework for nonlinear mixed-effects modeling that is less sensitive to outliers.
  • To illustrate the application of robust NLME models in pharmacokinetic data analysis and outlier detection.

Main Methods:

  • Utilized scale mixture of multivariate normal distributions, including heavy-tailed options like Student's t and contaminated normal distributions.
  • Adopted a Bayesian framework for statistical analysis.
  • Employed Markov Chain Monte Carlo (MCMC) methods for posterior analysis and model comparison using various criteria.

Main Results:

  • The proposed robust models effectively handle outliers by leveraging the tail behavior of chosen distributions.
  • Bayesian inference with MCMC provided robust parameter estimation and model comparison.
  • The implementation successfully identified outliers in a real pharmacokinetic dataset.

Conclusions:

  • Flexible distributions, specifically scale mixtures of multivariate normals, offer a robust alternative to normality assumptions in NLME models.
  • The developed Bayesian approach with MCMC is effective for robust inference and outlier detection in pharmacokinetic studies.
  • Contrasting results from normal and robust models highlight the practical benefits of the proposed methodology for data with potential outliers.